These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 17591033

  • 1. Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure.
    Gelderblom HC, Reesink HW, Beld MG, Weegink CJ, Jansen PL, Dijkgraaf MG, Zaaijer HL.
    Antivir Ther; 2007; 12(3):423-7. PubMed ID: 17591033
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical benefit of HCV core antigen assay in patients receiving interferon and ribavirin combination therapy].
    Higashimoto M, Takahashi M, Jokyu R, Saito H.
    Rinsho Byori; 2006 Feb; 54(2):111-5. PubMed ID: 16548229
    [Abstract] [Full Text] [Related]

  • 4. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays.
    Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S.
    Hepatology; 2000 Oct; 32(4 Pt 1):818-23. PubMed ID: 11003628
    [Abstract] [Full Text] [Related]

  • 5. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P.
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [Abstract] [Full Text] [Related]

  • 6. Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection.
    Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V.
    Aliment Pharmacol Ther; 2009 Sep 01; 30(5):477-86. PubMed ID: 19523175
    [Abstract] [Full Text] [Related]

  • 7. Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.
    Hofmann WP, Dries V, Herrmann E, Gärtner B, Zeuzem S, Sarrazin C.
    J Clin Virol; 2005 Apr 01; 32(4):289-93. PubMed ID: 15780807
    [Abstract] [Full Text] [Related]

  • 8. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ, Xie Y, Li ZQ.
    Hepatobiliary Pancreat Dis Int; 2005 Nov 01; 4(4):550-3. PubMed ID: 16286260
    [Abstract] [Full Text] [Related]

  • 9. Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay.
    Ferraro D, Giglio M, Bonura C, Di Marco V, Mondelli MU, Craxì A, Di Stefano R.
    J Viral Hepat; 2008 Jan 01; 15(1):66-70. PubMed ID: 18088247
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparable performance of TMA and Real-Time PCR in detecting minimal residual hepatitis C viraemia at the end of antiviral therapy.
    Bortoletto G, Campagnolo D, Mirandola S, Comastri G, Severini L, Pulvirenti FR, Alberti A.
    J Clin Virol; 2011 Mar 01; 50(3):217-20. PubMed ID: 21195023
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of hepatitis C virus RNA detection by transcription-mediated amplification with negative polymerase chain reaction during therapy with peginterferon alpha and ribavirin.
    Kadam JS, Gonzalez SA, Ahmed F, Menezes A, Jacobson IM.
    Dig Dis Sci; 2007 Oct 01; 52(10):2525-30. PubMed ID: 17406826
    [Abstract] [Full Text] [Related]

  • 14. Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage.
    Carabaich A, Ruvoletto M, Bernardinello E, Tono N, Cavalletto L, Chemello L, Gatta A, Pontisso P.
    J Med Virol; 2005 May 01; 76(1):55-60. PubMed ID: 15778969
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transcription-mediated amplification (TMA) for the assessment of viremia in hemodialysis patients with hepatitis C.
    Bastos DO, Perez RM, Silva IS, Lemos LB, Simonetti JP, Medina-Pestana JO, Silva AE, Ferraz ML.
    J Med Virol; 2012 Apr 01; 84(4):596-600. PubMed ID: 22337298
    [Abstract] [Full Text] [Related]

  • 17. [Quantification of hepatitis C virus RNA in serum].
    Kawai S, Yokosuka O.
    Nihon Rinsho; 2004 Jul 01; 62 Suppl 7(Pt 1):426-9. PubMed ID: 15359836
    [No Abstract] [Full Text] [Related]

  • 18. Dynamics of viremia in early hepatitis C virus infection.
    Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP.
    Transfusion; 2005 Jun 01; 45(6):994-1002. PubMed ID: 15934999
    [Abstract] [Full Text] [Related]

  • 19. Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance.
    Sarrazin C.
    J Clin Virol; 2002 Dec 01; 25 Suppl 3():S23-9. PubMed ID: 12467774
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.